Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Richard Brown

Hand Surgery La Jolla, CA Medical Doctor

NPI 1477571958 CMS profile 112424

9850 Genesee Avenue, Suite 210, La Jolla, CA 92037

Open in the dashboard

General payments

$2,515

34 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Richard Brown of La Jolla, CA is reported in the CMS Open Payments database as having received $2,515 across 34 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 52nd percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,084 3
2024 General $35 2
2023 General $108 4
2022 General $126 2
2021 General $605 4
2020 General $152 8
2019 General $405 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Richard Brown
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Richard Brown were reported at $1,084. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Richard Brown Hand Surgery median Middle half National median
2019 $405 $383 $106–$1,905 $163
2020 $152 $172 $51–$1,268 $114
2021 $605 $263 $71–$1,591 $132
2022 $126 $336 $87–$1,938 $149
2023 $108 $233 $81–$1,114 $160
2024 $35 $258 $88–$1,203 $164
2025 $1,084 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Becton, Dickinson and Company $1,025 2 payments
  2. Lupin Inc. $500 1 payment
  3. Endo Pharmaceuticals Inc. $499 15 payments
  4. Anika Therapeutics, Inc. $106 1 payment
  5. Ferring Pharmaceuticals Inc. $70 1 payment
  6. Ensemble Orthopedics, Inc $59 1 payment
  7. Acumed LLC $51 2 payments
  8. Zimmer Biomet Holdings, Inc. $49 2 payments
  9. Flexion Therapeutics, Inc. $37 2 payments
  10. Stryker Corporation $32 2 payments
  11. Other $87 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,245 3 payments
  2. Food and Beverage $770 30 payments
  3. Consulting Fee $500 1 payment
Products named General payments · program years 2019–2025
  1. XIAFLEX $499 15 payments
  2. Tactoset $106 1 payment
  3. Ensemble CMC $59 1 payment
  4. ACUMED Foot & Ankle $51 2 payments
  5. Zilretta $37 2 payments
  6. EBI Bone Healing System $34 1 payment
  7. VARIAX $32 2 payments
  8. OsteoMed $31 1 payment
  9. ACUMED Shoulder $31 1 payment
  10. TITAN-SHOULDER $21 1 payment
  11. Other $201 11 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

191

Median for Orthopedic Surgery: 203

Drug cost

$2,192

Median for Orthopedic Surgery: $1,433

Branded share of claims

87.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 24 $1,248
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 167 $944

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 112 billing codes

Paid by Medicare

$370,835

Of which drugs: $128,156

Medicare patients

748

Average age 75

Services billed

5,638

448 women, 300 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 64%
High blood pressure 55%
Ischemic heart disease 23%
Osteoporosis 21%
Cancer 17%
Depression 16%
Diabetes 15%
Atrial fibrillation 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, collagenase, clostridium histolyticum, 0.01 mg J0775 Office 25 2,610 $125,328
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 335 465 $2,414
Injection, bupivicaine, not otherwise specified, 0.5 mg J0665 Office 44 159 $2

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

34 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record